| Rubicon Research Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 15.41 | 15.21 | 5.07 | 5.07 | 5.07 |
| Reserves | 652.37 | 460.66 | 281.31 | 423.54 | 406.39 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 667.78 | 475.87 | 286.38 | 428.61 | 411.46 |
| Secured Loans | 328.70 | 303.81 | 317.55 | 154.78 | 81.63 |
| Unsecured Loans | 79.32 | 107.99 | 2.12 | 14.42 | 11.30 |
| Total Debt | 408.02 | 411.80 | 319.67 | 169.20 | 92.93 |
| Other Liabilities | 9.55 | 4.39 | 3.28 | 1.72 | 3.68 |
| Total Liabilities | 1,085.35 | 892.06 | 609.33 | 599.53 | 508.07 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 957.91 | 410.00 | 358.99 | 299.40 | 264.67 |
| Less: Accumulated Depreciation | 698.58 | 178.26 | 159.61 | 118.78 | 87.72 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 259.33 | 231.74 | 199.38 | 180.62 | 176.95 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 6.39 | 9.68 | 24.51 | 2.64 | 4.42 |
| Investments | 35.71 | 33.71 | 0.05 | 18.62 | 32.32 |
| Current Assets, Loans & Advances | |||||
| Inventories | 257.92 | 181.47 | 167.21 | 57.55 | 56.58 |
| Sundry Debtors | 501.41 | 252.05 | 224.98 | 233.63 | 153.83 |
| Cash and Bank Balance | 37.11 | 48.25 | 58.91 | 43.50 | 78.65 |
| Loans and Advances | 153.89 | 88.75 | 50.49 | 63.35 | 50.69 |
| Total Current Assets | 950.32 | 570.51 | 501.59 | 398.03 | 339.74 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 222.39 | 122.05 | 116.04 | 73.82 | 52.33 |
| Provisions | 33.18 | 2.50 | 22.89 | 1.07 | 1.01 |
| Total CL & Provisions | 255.58 | 124.55 | 138.93 | 74.90 | 53.34 |
| Net Current Assets | 694.75 | 445.96 | 362.65 | 323.13 | 286.40 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 1.77 | 0.92 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liability | 0.00 | 0.00 | 1.45 | 3.91 | 8.19 |
| Net Deferred Tax | 1.77 | 0.92 | -1.45 | -3.91 | -8.19 |
| Other Assets | 87.42 | 170.03 | 24.18 | 78.43 | 16.17 |
| Total Assets | 1,085.37 | 892.04 | 609.31 | 599.53 | 508.07 |
| Contingent Liabilities | 362.35 | 144.16 | 9.05 | 0.00 | 0.00 |